EPIGENETIC MECHANISM AND TARGETING DURING RESPONSE TO BRAFI/ANTI-EGFR THERAPY IN BRAF-MUTANT COLORECTAL CANCERS
$1,690,396FY2024Defense Health AgencyDOD
The Univeristy Of Texas M.D. Anderson Cancer Center
The Univeristy Of Texas M.D. Anderson Cancer Center